Wize Pharma ophthalix.com

Wize Pharma, Inc. (formerly known as OphthaliX, Inc.) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES). Wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of DES, and other ophthalmological illnesses, including Conjunctivochalasis (CCH) and Sjogren's syndrome (Sjogren's). LO2A is currently registered and marketed by its in...Show all

Wize Pharma, Inc. (formerly known as OphthaliX, Inc.) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including dry eye syndrome (DES). Wize has in-licensed certain rights to purchase, market,...Show all

See All Exits Recent Exits

Phone: +972-3-9241114

Fax:

123 West Nye Lane
Suite 129
Carson City, 89706
Nevada, United States

Wize Pharma - Investments & Acquisitions

Show Real Data Wize Pharma Investments
See all Recent Investments
Date Company Round Amount Co-investors
2017-11-16Wize Pharma (acquired by Ophthalix)Acq - P2P
2015-05-04Improved Vision SystemsAcquired
See all 2 investments